Scientific paper - Original scientific paper
Assessment of Perforin Expression in Peripheral Blood Lymphocytes in Psoriatic Patients During Exacerbation of Disease
Acta Dermato-Venereologica Supplementum, 211 (2000); 14-16. https://doi.org/10.1080/00015550050500059


Cite this document

Prpić, L., Štrbo, N., Sotošek, V., Gruber, F., Podack, E. R. & Rukavina, D. (2000). Assessment of Perforin Expression in Peripheral Blood Lymphocytes in Psoriatic Patients During Exacerbation of Disease. Acta Dermato-Venereologica Supplementum, 211., 14-16. doi: 10.1080/00015550050500059

Prpić, Larisa, et al. "Assessment of Perforin Expression in Peripheral Blood Lymphocytes in Psoriatic Patients During Exacerbation of Disease." Acta Dermato-Venereologica Supplementum, vol. 211, 2000, pp. 14-16. https://doi.org/10.1080/00015550050500059

Prpić, Larisa, Nataša Štrbo, Vlatka Sotošek, Franjo Gruber, Eckhard R. Podack and Daniel Rukavina. "Assessment of Perforin Expression in Peripheral Blood Lymphocytes in Psoriatic Patients During Exacerbation of Disease." Acta Dermato-Venereologica Supplementum 211 (2000): 14-16. https://doi.org/10.1080/00015550050500059

Prpić, L., et al. (2000) 'Assessment of Perforin Expression in Peripheral Blood Lymphocytes in Psoriatic Patients During Exacerbation of Disease', Acta Dermato-Venereologica Supplementum, 211, pp. 14-16. doi: 10.1080/00015550050500059

Prpić L, Štrbo N, Sotošek V, Gruber F, Podack ER, Rukavina D. Assessment of Perforin Expression in Peripheral Blood Lymphocytes in Psoriatic Patients During Exacerbation of Disease. Acta Dermato-Venereologica Supplementum [Internet]. 2000 [cited 2024 April 23];211:14-16. doi: 10.1080/00015550050500059

L. Prpić, N. Štrbo, V. Sotošek, F. Gruber, E. R. Podack and D. Rukavina, "Assessment of Perforin Expression in Peripheral Blood Lymphocytes in Psoriatic Patients During Exacerbation of Disease", Acta Dermato-Venereologica Supplementum, vol. 211, pp. 14-16, 2000. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:001688. [Accessed: 23 April 2024]